Biocon to start clinical trials for diabetic drug
Biocon India Ltd, the Bangalore-based pharma-biotech company, is planning to try out application of mycophenolate mofetil popularly known as CellCept, an immunosuppressive drug, to treat diabetic
Biocon India Ltd, the Bangalore-based pharma-biotech company, is planning to try out application of mycophenolate mofetil popularly known as CellCept, an immunosuppressive drug, to treat diabetic